BN
Bionik Laboratories Corp.
BNKL · OTC
$0.00 +0.00% (+$0.00)
Market Cap $1.25K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.00x
PEG N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 5.71%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 273.99%
Op. margin 267.29%
FCF margin 187.64%
Quality
10 /100
Poor ROA 147.11%
Asset turnover 0.54x
ROIC 448.84%
Debt
21 /100
High Int. coverage -45.16x
Current ratio 1.20x
Net debt/EBITDA N/A
Stability
31 /100
Unstable Rev. volatility 43.41%
EPS volatility 13.71%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BNKL
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Richard Paul Russo Jr.
Employees
12
Headquarters
Watertown